Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,006 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigating toxicity specific to adjuvanted vaccines.
Matsumoto M, Komatsu SI, Ikeda T, Shimomura K, Watanabe K, Hirabayashi K, Sawada JI, Maki K, Shinoda K, Fueki O, Onodera H. Matsumoto M, et al. Among authors: maki k. Regul Toxicol Pharmacol. 2017 Dec;91:29-38. doi: 10.1016/j.yrtph.2017.09.003. Epub 2017 Sep 6. Regul Toxicol Pharmacol. 2017. PMID: 28888957 Review.
Considerations for non-clinical safety studies of therapeutic peptide vaccines.
Matsumoto M, Komatsu S, Tsuchimoto M, Matsui H, Watanabe K, Nakamura K, Amakasu K, Ito K, Fueki O, Sawada J, Maki K, Onodera H. Matsumoto M, et al. Among authors: maki k. Regul Toxicol Pharmacol. 2014 Oct;70(1):254-60. doi: 10.1016/j.yrtph.2014.06.029. Epub 2014 Jul 17. Regul Toxicol Pharmacol. 2014. PMID: 25042360
Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals.
Hirabayashi Y, Maki K, Kinoshita K, Nakazawa T, Obika S, Naota M, Watanabe K, Suzuki M, Arato T, Fujisaka A, Fueki O, Ito K, Onodera H. Hirabayashi Y, et al. Among authors: maki k. Nucleic Acid Ther. 2021 Apr;31(2):114-125. doi: 10.1089/nat.2020.0879. Epub 2021 Jan 19. Nucleic Acid Ther. 2021. PMID: 33470890 Free PMC article.
Nonclinical safety assessment of engineered T cell therapies.
Lebrec H, Maier CC, Maki K, Ponce R, Shenton J, Green S. Lebrec H, et al. Among authors: maki k. Regul Toxicol Pharmacol. 2021 Dec;127:105064. doi: 10.1016/j.yrtph.2021.105064. Epub 2021 Oct 14. Regul Toxicol Pharmacol. 2021. PMID: 34656748 Free article. Review.
Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan.
Yamaguchi T, Uchida E, Okada T, Ozawa K, Onodera M, Kume A, Shimada T, Takahashi S, Tani K, Nasu Y, Mashimo T, Mizuguchi H, Mitani K, Maki K. Yamaguchi T, et al. Among authors: maki k. Hum Gene Ther. 2020 Oct;31(19-20):1043-1053. doi: 10.1089/hum.2020.156. Epub 2020 Sep 17. Hum Gene Ther. 2020. PMID: 32731837 Free PMC article. Review.
Interleukin 7 receptor-deficient mice lack gammadelta T cells.
Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H, Yokomuro K, Miyazaki JI, Ikuta K. Maki K, et al. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7172-7. doi: 10.1073/pnas.93.14.7172. Proc Natl Acad Sci U S A. 1996. PMID: 8692964 Free PMC article.
1,006 results